Flu Levels Rising Across U.S. After Period of Decline

RSV and COVID-19 activity is also high in certain parts of the country, and vaccine uptake for all three respiratory illnesses remains low.

Influenza levels rose across the U.S. over the last week after a period of declining case numbers. CIDRAP has the news.

RSV and COVID-19 activity is also high in certain parts of the country. However, “overall levels of acute respiratory illness are low to moderate in most of the country, with only Alabama and Arkansas in the high category.” COVID-19 cases are unchanged since last week, but levels are growing or likely growing in 11 states; flu cases are trending upward in 13 states, and RSV cases in 21 states.

90.5% of influenza A(H3N2) viruses collected since September 28 that underwent additional genetic testing belonged to subclade K. Influenza B, meanwhile, has been gaining ground across the country. Also, for the week ending January 24, “4.7% of healthcare visits were for respiratory illness, above baseline.” The flu hospitalization rate overall has been trending downward.

Hospitalizations, however, are increasing “among infants under age 1, and ED visits among children aged 5 to 17 years are climbing.” The CDC also noted that “national COVID-19, flu, and RSV vaccine uptake is low for both adults and children.”

About the Author

Matt MacKenzie

Matt MacKenzie

Associate Editor

Matt MacKenzie is Senior Staff Writer and Associate Editor of Healthcare Purchasing News (HPN), where he leads daily news coverage and contributes in-depth features on healthcare supply chain, sterile processing, infection prevention and clinical operations. Through industry reporting and expert interviews, he examines the trends, technologies and operational challenges shaping healthcare purchasing and patient care. 

Sign up for our eNewsletters
Get the latest news and updates